Viridian Therapeutics Inc (VRDN)
13.01
+0.23
(+1.80%)
USD |
NASDAQ |
Jun 28, 16:00
13.00
-0.01
(-0.08%)
After-Hours: 20:00
Viridian Therapeutics Shareholders Equity (Quarterly): 582.53M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 582.53M |
| December 31, 2023 | 442.02M |
| September 30, 2023 | 283.58M |
| June 30, 2023 | 315.86M |
| March 31, 2023 | 350.55M |
| December 31, 2022 | 395.06M |
| September 30, 2022 | 409.01M |
| June 30, 2022 | 141.90M |
| March 31, 2022 | 166.64M |
| December 31, 2021 | 187.72M |
| September 30, 2021 | 204.59M |
| June 30, 2021 | 98.91M |
| March 31, 2021 | 106.00M |
| December 31, 2020 | 120.04M |
| September 30, 2020 | 21.04M |
| June 30, 2020 | 21.17M |
| March 31, 2020 | 27.00M |
| December 31, 2019 | 15.75M |
| September 30, 2019 | 23.17M |
| June 30, 2019 | 33.44M |
| March 31, 2019 | 40.96M |
| Date | Value |
|---|---|
| December 31, 2018 | 51.34M |
| September 30, 2018 | 60.72M |
| June 30, 2018 | 67.67M |
| March 31, 2018 | 72.71M |
| December 31, 2017 | 38.51M |
| September 30, 2017 | 38.98M |
| June 30, 2017 | 41.34M |
| March 31, 2017 | 47.99M |
| December 31, 2016 | -0.326M |
| September 30, 2016 | 4.686M |
| June 30, 2016 | 6.437M |
| March 31, 2016 | 8.339M |
| December 31, 2015 | 10.41M |
| September 30, 2015 | 12.63M |
| June 30, 2015 | 10.94M |
| March 31, 2015 | 13.15M |
| December 31, 2014 | 5.991M |
| September 30, 2014 | 7.530M |
| June 30, 2014 | 8.463M |
| March 31, 2014 | 1.625M |
| December 31, 2013 | -23.89M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
15.75M
Minimum
Dec 2019
582.53M
Maximum
Mar 2024
205.92M
Average
166.64M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 229.89M |
| Electromed Inc | 42.54M |
| Xtant Medical Holdings Inc | 47.68M |
| Asensus Surgical Inc | 13.02M |
| Myomo Inc | 10.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 630.38M |
| Total Liabilities (Quarterly) | 47.85M |
| Debt to Equity Ratio | 0.0349 |
| Current Ratio | 23.99 |
| Net Debt Paydown Yield | -0.28% |